Effects of Antibodies to White Blood Cells on Platelet Transfusion Patients
Completed
Conditions studied: Healthy, Transfusion Reactions
In brief
This study will determine if transfusion of platelets containing HLA antibodies (certain antibodies to white blood cells) are more likely to cause transfusion reactions than transfusion of platelets that do not contain HLA antibodies. People 18 years of age or older who donate platelets at the NIH Clinical Center may be eligible for this study. An extra tube of blood (about one teaspoon) is obtained from participating donors at the time of their donation at the NIH Platelet Center. The blood plasma in the extra tube is tested for HLA antibodies and antibodies to certain white blood cells called granulocytes. The research sample is assigned a code number for identification and sent to the HLA Laboratory in the Department of Transfusion Medicine.
Key facts
- Study ID
- NCT00460122
- Run by
- National Institutes of Health Clinical Center (CC)
- People needed
- 135
- Starts
- 2007-04-10
- Expected to finish
- 2012-08-10
- Last updated by the study team
- 2019-12-12
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may not qualify if…
- Donors are not eligible to donate platelets in the DTM
Where it is running
- National Institutes of Health Clinical Center, 9000 Rockville Pike — Bethesda, Maryland, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.